Captrust Financial Advisors
- SEC CIK
- 0001512024
- Latest filing
- Aug 13, 2026
PVCT holding history
Provectus Biopharmaceuticals, Inc. in every 13F filed by Captrust Financial Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PVCT overviewAll 13F holders of PVCTFull Q2 2026 holdings
- Shares (Q3 2022)
- 0
- Sold out in Q3 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2022 | 0 | $0 | 0.0% | −57,659−100.0% | Sold out | Holders |
| Q2 2022 | 57,659 | $3.00K | <0.1% | +37,257+182.6% | Added | Holders |
| Q1 2022 | 20,402 | $1.00K | <0.1% | −22,257−52.2% | Reduced | Holders |
| Q4 2021 | 42,659 | $2.00K | <0.1% | +20,202+90.0% | Added | Holders |
| Q3 2021 | 22,457 | $1.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 22,457 | $2.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 22,457 | $2.00K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.